Drug Type Recombinant coagulation factor, Biosimilar |
Synonyms Eptacog alfa Biosimilar (Beijing Zhidao Biological Technology Co., Ltd.), Factor VIIa biosimilar( Leto Laboratories), EN 006 + [1] |
Target |
Action stimulants |
Mechanism F10 stimulants(Coagulation factor X stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |


| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia A | Discovery | China | 01 Nov 2024 | |
| Hemophilia B | Discovery | China | 01 Nov 2024 |






